COLL

NASDAQ 已收盘

Collegium Pharmaceutical

21.84 USD
-0.97-4.25%
盘后 28.12 0.00%
2026-09-15
市值
$722.41M
市盈率
15.79
EPS
1.41
股息率
52 周区间
21.65 – 50.79
成交量
954.00K
Beta
0.72
目标价
48.86
52W 低 21.6552W 高 50.79
价格走势

公司简介

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company’s portfolio includes Jornay PM, a central nervous system stimulant prescription medicine that contains methylphenidate HCl for the treatment of attention deficit hyperactivity disorder; Belbuca, a buccal film that contains buprenorphine for severe and persistent pain that requires an extended treatment period; Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxyco...